1. Volume 141, Issue 2, Pages 460-468 (August 2011)
Durability of Radiofrequency Ablation in Barrett's Esophagus With Dysplasia 
Nicholas J. Shaheen, Bergein F. Overholt, Richard E. Sampliner, Herbert C. Wolfsen, Kenneth K. Wang, David E. Fleischer, Virender K. Sharma, Glenn M. Eisen, M. Brian Fennerty, John G. Hunter, Mary P. Bronner, John R. Goldblum, Ana E. Bennett, Hiroshi Mashimo, Richard I. Rothstein, Stuart R. Gordon, Steven A. Edmundowicz, Ryan D. Madanick, Anne F. Peery, V. Raman Muthusamy, Kenneth J. Chang, Michael B. Kimmey, Stuart J. Spechler, Ali A. Siddiqui, Rhonda F. Souza, Anthony Infantolino, John A. Dumot, Gary W. Falk, Joseph A. Galanko, Blair A. Jobe, Robert H. Hawes, Brenda J. Hoffman, Prateek Sharma, Amitabh Chak, Charles J. Lightdale 
Gastroenterology 
Volume 141, Issue 2, Pages (August 2011)
DOI: /j.gastro
Copyright © 2011 AGA Institute Terms and Conditions

2. Figure 1 Flow diagram of subjects progressing through the trial.
Gastroenterology  , DOI: ( /j.gastro )
Copyright © 2011 AGA Institute Terms and Conditions

3. Figure 2
Kaplan–Meier analysis of the durability of complete eradication of dysplasia. All subjects in this analysis achieved complete eradication of dysplasia at or after the 12-month end point (n = 110), and time 0 for this analysis is the first finding of complete eradication of dysplasia at or after month 12. For purposes of this analysis, any recurrent dysplasia noted after initially achieving CE-D was considered a failure, even if such recurrence was followed by focal RFA and re-establishment of CE-D.
Gastroenterology  , DOI: ( /j.gastro )
Copyright © 2011 AGA Institute Terms and Conditions

4. Figure 3
Kaplan–Meier analysis of the durability of complete eradication of intestinal metaplasia. All subjects in this analysis achieved complete eradication of dysplasia at or after the 12-month end point (n = 108), and time 0 for this analysis is the first finding of complete eradication of intestinal metaplasia at or after month 12. For purposes of this analysis, any recurrent intestinal metaplasia noted after initially achieving CE-IM was considered a failure, even if such recurrence was followed by focal RFA and re-establishment of CE-IM.
Gastroenterology  , DOI: ( /j.gastro )
Copyright © 2011 AGA Institute Terms and Conditions